Lauren J. Rogak

8.1k total citations · 1 hit paper
47 papers, 3.4k citations indexed

About

Lauren J. Rogak is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lauren J. Rogak has authored 47 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 17 papers in Economics and Econometrics and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lauren J. Rogak's work include Cancer survivorship and care (19 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Economic and Financial Impacts of Cancer (8 papers). Lauren J. Rogak is often cited by papers focused on Cancer survivorship and care (19 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Economic and Financial Impacts of Cancer (8 papers). Lauren J. Rogak collaborates with scholars based in United States and Australia. Lauren J. Rogak's co-authors include Ethan Basch, Antonia V. Bennett, Thomas M. Atkinson, Amylou C. Dueck, Deborah Schrag, Laura Sit, Howard I. Scher, Mark G. Kris, M. Fruscione and Allison Barz Leahy and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Quality of Life Research.

In The Last Decade

Lauren J. Rogak

46 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

2015 1.7k citations Ethan Basch, Allison M. Deal et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lauren J. Rogak United States	22	2.1k	1.0k	721	626	491	47	3.4k
Allison Barz Leahy United States	15	2.2k 1.0×	1.1k 1.1×	771 1.1×	576 0.9×	403 0.8×	43	3.5k
Laura Sit United States	14	1.9k 0.9×	915 0.9×	691 1.0×	648 1.0×	367 0.7×	29	3.4k
Antonia V. Bennett United States	28	2.6k 1.2×	1.2k 1.2×	824 1.1×	826 1.3×	571 1.2×	121	4.5k
M. Fruscione United States	9	1.6k 0.8×	776 0.8×	560 0.8×	488 0.8×	309 0.6×	20	2.7k
Dana S. Wollins United States	24	1.8k 0.8×	1.2k 1.2×	777 1.1×	404 0.6×	687 1.4×	39	4.0k
Dorothy Dulko United States	11	1.5k 0.7×	842 0.8×	549 0.8×	376 0.6×	245 0.5×	22	2.3k
Larissa Nekhlyudov United States	41	3.1k 1.5×	1.4k 1.4×	1.0k 1.4×	735 1.2×	607 1.2×	174	5.1k
Kim Cocks United Kingdom	31	1.9k 0.9×	362 0.4×	384 0.5×	633 1.0×	303 0.6×	112	3.7k
Ryan David Nipp United States	37	2.3k 1.1×	1.8k 1.8×	927 1.3×	664 1.1×	658 1.3×	243	4.5k
Jennifer L. Malin United States	39	3.0k 1.4×	2.0k 1.9×	907 1.3×	640 1.0×	911 1.9×	132	5.7k

Countries citing papers authored by Lauren J. Rogak

Since Specialization

Citations

This map shows the geographic impact of Lauren J. Rogak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren J. Rogak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren J. Rogak more than expected).

Fields of papers citing papers by Lauren J. Rogak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren J. Rogak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren J. Rogak. The network helps show where Lauren J. Rogak may publish in the future.

Co-authorship network of co-authors of Lauren J. Rogak

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren J. Rogak. A scholar is included among the top collaborators of Lauren J. Rogak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren J. Rogak. Lauren J. Rogak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Minji K., Sandra A. Mitchell, Ethan Basch, et al.. (2024). Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®). Quality of Life Research. 34(2). 495–507. 2 indexed citations

Langlais, Blake, Amylou C. Dueck, Heidi Kosiorek, et al.. (2024). Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms. Leukemia & lymphoma. 65(10). 1465–1473. 3 indexed citations

Mazza, Gina L., Amylou C. Dueck, Brenda Ginos, et al.. (2024). Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39). Quality of Life Research. 33(7). 1985–1995. 9 indexed citations

Thanarajasingam, Gita, Ethan Basch, Carolyn Mead‐Harvey, et al.. (2022). An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment. Value in Health. 25(7). 1081–1086. 12 indexed citations

Blinder, Victoria, Allison M. Deal, Brenda Ginos, et al.. (2022). A randomized controlled trial of routine financial toxicity screening via electronic patient-reported outcomes (AFT-39).. Journal of Clinical Oncology. 40(28_suppl). 180–180. 2 indexed citations

Langlais, Blake, Gina L. Mazza, Gita Thanarajasingam, et al.. (2021). Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data. Journal of Pain and Symptom Management. 63(2). 311–320. 15 indexed citations

Mazza, Gina L., M. Petersen, Brenda Ginos, et al.. (2021). Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2. Quality of Life Research. 31(4). 1069–1080. 3 indexed citations

Postow, Michael A., Jessica A. Lavery, Shrujal S. Baxi, et al.. (2020). Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 8(1). e000260–e000260. 34 indexed citations

Nipp, Ryan David, Nora Horick, Allison M. Deal, et al.. (2020). Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer. Annals of Oncology. 31(1). 123–130. 30 indexed citations

10.

Dueck, Amylou C., Claus Becker, Lauren J. Rogak, et al.. (2020). Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.. Journal of Clinical Oncology. 38(15_suppl). 7018–7018. 3 indexed citations

11.

Schoen, Martin W., Ethan Basch, Lori L. Hudson, et al.. (2018). Software for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR Human Factors. 5(3). e10070–e10070. 19 indexed citations

12.

Atkinson, Thomas M., Bryce B. Reeve, Amylou C. Dueck, et al.. (2018). Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events. Journal of Patient-Reported Outcomes. 2(1). 56–56. 3 indexed citations

13.

Atkinson, Thomas M., Lauren J. Rogak, Sean J. Ryan, et al.. (2017). Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting. Journal of Cancer Research and Clinical Oncology. 143(4). 735–743. 31 indexed citations

14.

Bennett, Antonia V., Amylou C. Dueck, Sandra A. Mitchell, et al.. (2016). Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Health and Quality of Life Outcomes. 14(1). 24–24. 94 indexed citations

15.

Basch, Ethan, Allison M. Deal, Mark G. Kris, et al.. (2015). Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. Journal of Clinical Oncology. 34(6). 557–565. 1668 indexed citations breakdown →

16.

Hay, Jennifer L., Thomas M. Atkinson, Bryce B. Reeve, et al.. (2013). Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Quality of Life Research. 23(1). 257–269. 121 indexed citations

17.

Atkinson, Thomas M., Susan Halabi, Antonia V. Bennett, et al.. (2012). Measurement of Affective and Activity Pain Interference Using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903. Pain Medicine. 13(11). 1417–1424. 20 indexed citations

18.

Mitchell, Sandra A., Christine Nichols, Steven B. Clauser, et al.. (2012). Validation of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women receiving treatment for metastatic breast cancer.. Journal of Clinical Oncology. 30(15_suppl). 9144–9144. 2 indexed citations

19.

Basch, Ethan, Bryce B. Reeve, Sandra A. Mitchell, et al.. (2011). Electronic Toxicity Monitoring and Patient-Reported Outcomes. The Cancer Journal. 17(4). 231–234. 43 indexed citations

20.

Rogak, Lauren J., et al.. (2010). Substance Abuse in Cancer Pain. Current Pain and Headache Reports. 14(4). 268–275. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact